PAHC — PHIBRO ANIMAL HEALTH CORP
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1069899 ·
Last close
$31.53
Market Cap
$664.30M
52W High
$59.83
52W Low
$28.13
ADV30
449,933
Next earnings
2026-05-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 383,543,000 | 125,675,000 | 44,653,000 | 24,024,000 | 1,445,118,000 | 54,929,000 | 1,083,291,000 |
| Dec 2025 | 373,910,000 | 132,656,000 | 50,326,000 | 27,459,000 | 1,405,553,000 | 55,486,000 | 1,073,192,000 |
| Sep 2025 | 363,893,000 | 119,783,000 | 51,260,000 | 26,527,000 | 1,385,524,000 | 72,769,000 | 1,073,843,000 |
| Jun 2025 | 378,697,000 | 110,009,000 | 33,718,000 | 17,224,000 | 1,360,900,000 | 68,039,000 | 1,075,218,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$93,080,000
Investing CF
$-63,483,000
Financing CF
$-42,634,000
CapEx
$-45,791,000
Dividends Paid
$-19,457,000
Buybacks
—
EPS Diluted TTM
$2.25
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$316,959,000
Inventory
$517,347,000
Receivables
$215,872,000
ST Investments
$19,022,000
EBIT TTM
$167,579,000
Pretax Income TTM
$126,227,000
Interest Exp TTM
$41,352,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,500,043,008
EBITDA
$234,754,000
Free Cash Flow
$-17,678,250
Enterprise Value
$1,989,546,496
Total Cash
$78,138,000
Total Debt
$788,678,976
Shares Out
21,068,682
Trailing EPS
$2.33
Book Value
$8.92
ROE
30.3%
ROA
8.4%
Div Yield
1.52%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 1,296,215,000 | 110,465,000 | 48,264,000 | 1,360,900,000 | 1,075,218,000 | — | 80,124,000 |
| Jun 2024 | 1,017,679,000 | 53,315,000 | 2,416,000 | 982,184,000 | 725,543,000 | — | 87,594,000 |
| Jun 2023 | 977,889,000 | 71,847,000 | 32,606,000 | 971,397,000 | 688,888,000 | — | 13,310,000 |
| Jun 2022 | 942,261,000 | 78,986,000 | 49,175,000 | 931,699,000 | 669,257,000 | — | 31,649,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$3.34
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $22.50 · spot: $32.28 · call volume: 69 · put volume: 52
Expected Move to 2026-12-18:
±$12.32
(38.18%) —
implied range
$19.95 –
$44.60
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OCS | Oculis Holding AG | $669.70M | $11.09 | — |
| CTMX | CytomX Therapeutics, Inc. | $655.29M | $3.01 | — |
| CLYM | Climb Bio, Inc. | $655.09M | $11.44 | — |
| SMNR | Semnur Pharmaceuticals, Inc. | $644.59M | $2.80 | — |
| DSGN | Design Therapeutics, Inc. | $685.15M | $10.97 | — |
News headlines (Yahoo Finance, 1h cache)
Should You Continue to Hold PAHC Stock in Your Portfolio?
2026-06-15 12:52 · Yahoo
Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
2026-06-13 16:40 · Yahoo
PAHC Stock: What's Driving Phibro's Animal Health Growth
2026-06-12 12:27 · Yahoo
3 Value Stocks with Questionable Fundamentals
2026-06-11 13:05 · Yahoo
Is PAHC Undervalued at 10x Earnings vs Peers?
2026-06-11 12:53 · Yahoo
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
2026-06-10 13:40 · Yahoo
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value
2026-06-06 18:07 · Yahoo
1 Growth Stock with All-Star Potential and 2 We Question
2026-06-05 19:12 · Yahoo
Why Phibro Animal Health (PAHC) Stock Is Trading Up Today
2026-06-04 00:23 · Yahoo
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
2026-06-03 15:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.